Renaissance Technologies’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$141K Buy
+105,687
New +$141K ﹤0.01% 3243
2025
Q1
Sell
-100,000
Closed -$163K 3748
2024
Q4
$163K Buy
100,000
+76,800
+331% +$125K ﹤0.01% 3216
2024
Q3
$88.6K Buy
+23,200
New +$88.6K ﹤0.01% 3276
2024
Q2
Sell
-354,800
Closed -$1.41M 3849
2024
Q1
$1.41M Buy
354,800
+234,100
+194% +$927K ﹤0.01% 2256
2023
Q4
$600K Buy
+120,700
New +$600K ﹤0.01% 2701
2023
Q3
Sell
-22,862
Closed -$115K 3981
2023
Q2
$115K Sell
22,862
-342,875
-94% -$1.72M ﹤0.01% 3442
2023
Q1
$2.25M Buy
365,737
+118,400
+48% +$728K ﹤0.01% 1961
2022
Q4
$3.27M Sell
247,337
-74,987
-23% -$990K ﹤0.01% 1761
2022
Q3
$957K Sell
322,324
-68,713
-18% -$204K ﹤0.01% 2525
2022
Q2
$1.43M Sell
391,037
-274,000
-41% -$1,000K ﹤0.01% 2453
2022
Q1
$4.12M Buy
665,037
+220,300
+50% +$1.36M ﹤0.01% 1738
2021
Q4
$3.6M Buy
444,737
+78,900
+22% +$639K ﹤0.01% 1738
2021
Q3
$5.45M Sell
365,837
-89,620
-20% -$1.34M 0.01% 1417
2021
Q2
$5.72M Sell
455,457
-212,290
-32% -$2.66M 0.01% 1553
2021
Q1
$3.04M Sell
667,747
-160,974
-19% -$732K ﹤0.01% 1957
2020
Q4
$1.77M Buy
828,721
+44,864
+6% +$96K ﹤0.01% 2194
2020
Q3
$1.83M Buy
783,857
+161,185
+26% +$375K ﹤0.01% 2192
2020
Q2
$1.25M Buy
622,672
+313,051
+101% +$629K ﹤0.01% 2438
2020
Q1
$226K Buy
309,621
+189,352
+157% +$138K ﹤0.01% 3070
2019
Q4
$319K Buy
120,269
+28,700
+31% +$76.1K ﹤0.01% 3056
2019
Q3
$309K Buy
91,569
+13,100
+17% +$44.2K ﹤0.01% 3027
2019
Q2
$470K Buy
78,469
+38,105
+94% +$228K ﹤0.01% 3013
2019
Q1
$299K Buy
40,364
+12,103
+43% +$89.7K ﹤0.01% 3095
2018
Q4
$181K Buy
28,261
+15,081
+114% +$96.6K ﹤0.01% 3155
2018
Q3
$216K Buy
13,180
+845
+7% +$13.8K ﹤0.01% 3129
2018
Q2
$254K Buy
12,335
+165
+1% +$3.4K ﹤0.01% 3017
2018
Q1
$287K Buy
12,170
+3,430
+39% +$80.9K ﹤0.01% 3092
2017
Q4
$1.64M Buy
8,740
+105
+1% +$19.7K ﹤0.01% 2454
2017
Q3
$1.85M Buy
8,635
+5,595
+184% +$1.2M ﹤0.01% 2329
2017
Q2
$624K Buy
3,040
+1,410
+87% +$289K ﹤0.01% 2705
2017
Q1
$297K Buy
+1,630
New +$297K ﹤0.01% 2909